RBM3 and cancer: These ideas are potentially challenged, however, by studies in astrocytoma101 and erythroblastosis virus E26 oncogene homolog-positive prostate cancer102 (but see29,90), which show that nuclear expression of RBM3 is positively associated with higher grade cancers and predicts a poorer clinical outcome.